Novartis (India)

Parent institution: Novartis (Switzerland)

ROR: 00dhvr506

OpenAlex ID: I4210090302

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

2015 · Iain B McInnes, Philip J Mease, et al. · The Lancet · 859

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

2021 · Stephen J Schuster, Constantine S Tam, et al. · The Lancet Oncology · 584

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

2019 · Jens Kuhle, Harald Kropshofer, et al. · Neurology · 569

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

2020 · Reinhard Dummer, Axel Hauschild, et al. · New England Journal of Medicine · 408

PDF

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

2022 · Theodore W. Laetsch, Shannon L. Maude, et al. · Journal of Clinical Oncology · 383

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

2011 · Marcus Maurer, Sabine Altrichter, et al. · Journal of Allergy and Clinical Immunology · 360

PDF

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

2010 · Felicia Cosman, Erik Fink Eriksen, et al. · Journal of Bone and Mineral Research · 359

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

2014 · A. Blauvelt, J.C. Prinz, et al. · British Journal of Dermatology · 323

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data

2019 · A. Deodhar, P. J. Mease, et al. · Arthritis Research & Therapy · 292

PDF

The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)

2014 · Dennis M. Black, Ian R. Reid, et al. · Journal of Bone and Mineral Research · 253

PDF

Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study

2018 · Rima Nabbout, Elena Belousova, et al. · Epilepsia Open · 244

PDF

Spiroindolone KAE609 for Falciparum and Vivax Malaria

2014 · Nicholas J. White, Sasithon Pukrittayakamee, et al. · New England Journal of Medicine · 240

PDF

Initiating Sacubitril/Valsartan (LCZ696) in Heart Failure: Results of TITRATION, a Double-Blind, Randomized Comparison of Two Uptitration Regimens

2016 · Michele Senni, John J.V. McMurray, et al. · European Journal of Heart Failure · 236

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

2017 · Nagaendran Kandiah, Ming-Chyi Pai, et al. · Clinical Interventions in Aging · 229

PDF

Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes

2018 · Hillel P. Cohen, Andrew Blauvelt, et al. · Drugs · 224

PDF

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

2017 · Denis Soulières, Sandrine Faivre, et al. · The Lancet Oncology · 219

Suzuki–Miyaura cross coupling reaction: recent advancements in catalysis and organic synthesis

2021 · Brijesh S. Kadu · Catalysis Science & Technology · 218

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

2019 · Darren R. Hargrave, Eric Bouffet, et al. · Clinical Cancer Research · 214

Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data

2016 · Fernanda Tavares Da Silva, Bernard Gonik, et al. · Vaccine · 210

PDF

Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies

2021 · Petros Efthimiou, Apostolos Kontzias, et al. · Seminars in Arthritis and Rheumatism · 197

PDF

Detection and accurate false discovery rate control of differentially methylated regions from whole genome bisulfite sequencing

2018 · Keegan Korthauer, Sutirtha Chakraborty, et al. · Biostatistics · 197

PDF

Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials

2019 · Stefan Schreiber, Jean-Frederic Colombel, et al. · Annals of the Rheumatic Diseases · 195

PDF

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

2020 · Xenofon Baraliakos, Laure Gossec, et al. · Annals of the Rheumatic Diseases · 192

PDF

TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study

2018 · Petrus J. de Vries, Elena Belousova, et al. · Orphanet Journal of Rare Diseases · 184

PDF

Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults

2020 · Daniel Rooks, Therese Swan, et al. · JAMA Network Open · 175

PDF

Works count: 1,527

Citation count: 41,330